₹ 80 /Box Get Latest Price
Esomeprazole Capsules
TYPICAL USAGE:Gastric ulcer, gastro-esophageal reflux disease,zollinger-ellison syndrome.
MECHANISM OF ACTION:Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. By acting specifically on the proton pump, Esomeprazole blocks the final step in acid production, thus reducing gastric acidity.
₹ 25 /Bottle Get Latest Price
We manufacture "Magaldrate, Simethicone & Oxetacaine Suspension"
Each 5 ml contains :- | |
Magaldrate IP | 540 mg |
Simethicone IP | 50 mg |
Oxetacaine BP | 10 mg |
In a flavored syrup free base |
₹ 125 /Box Get Latest Price
Lansoprazole Orally Disintegrating Tablets
Each uncoated tablet contains :-
Lansoprazole......................15 mg
(as enteric coated pellets)
Commonly Used for - Peptic ulcer, acid-related dyspepsia, gastro-oesophageal reflux disease(GERD), prevention and treatment of NSAIDs related ulcers, H.pylori infection, erosive oesophagitis
Mechanism of action - Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach.
₹ 40 /Box Get Latest Price
Ranitidine Hydrochloride Tablets - 150 mg
TYPICAL USAGE:Benign duodenal and gastric ulcer, Reflux oesophagitis,Acid peptic disease.
MECHANISM OF ACTION:Ranitidine blocks histamine H2-receptors in the stomach and prevents histamine-mediated gastric acid secretion. It does not affect pepsin secretion, pentagastrin-stimulated factor secretion or serum gastrin.
₹ 60 /box Get Latest Price
Minimum order quantity: 50000 box
Pantoprazole - 40 mg Tablets (Enteric Coated)
TYPICAL USAGE: Duodenal ulcer. Gastric ulcer. Reflux oesophagitis. Prophylaxis of NSAID associated peptic ulcer. Zollinger-ellison syndrome and other hypersecretory states.
MECHANISM OF ACTION: Pantoprazole is a proton pump inhibitor (PPI) that suppresses the final step in gastric acid production by forming a covalent bond to two sites of the (H+,K+ )- ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect is dose- related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.
Rajat Gupta (Managing Director)
Dwarkesh Pharmaceuticals Private Limited
Plot No. 4801/5, Behind Indogerman Tools, Phase - 4, GIDC
Vatva, Ahmedabad - 382445, Gujarat, India